E. Thomson

发表

Simple Renal Cysts in Hypertensive Patients: Relation between Cyst Growing and Anti-Hypertensive Therapy

A. Primavera, R. Tenaglia, F. Cuccurullo, 2003, International journal of immunopathology and pharmacology.

ras Mutations in Preleukaemia, in Patients Following Cytotoxic Therapy and in Normal Subjects

J. Whittaker, A. Jacobs, R. Padua, 1991 .

Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area

R. Madhok, J. Hunter, I. McInnes, 2001, Annals of the rheumatic diseases.

Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.

R. Madhok, T. Pullar, J. Hunter, 1996, Annals of the rheumatic diseases.

Is rheumatoid arthritis becoming a milder disease? Or are we starting second-line therapy in patients with milder disease?

R. Madhok, J. Hunter, I. McInnes, 1996, British journal of rheumatology.

Lifestyle Influences on Outcome in Rheumatoid Arthritis

R. Madhok, J. Hamilton, D. Porter, 2000, Scottish medical journal.

Bioavailability, safety and immunogenicity of biosimilar infliximab (BOW015) compared to reference infliximab.

J. Kay, M. Wyand, C. Lassen, 2016, International journal of clinical pharmacology and therapeutics.

A phase 3, randomized, bouble-blind, active comparator study of the efficacy and safety of bBow015, a biosimilar infliximab, in patients with active rheumatoid arthritis on stable methotrexate doses

A. Chopra, S. Chandrashekara, Mathew Thomas, 2014 .

Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis

R. Madhok, D. Porter, H. Capell, 1997, Annals of the rheumatic diseases.

Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial

R. Madhok, F. W. Poon, J. Hunter, 2004, Annals of the rheumatic diseases.

Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study

R. Madhok, H. Capell, R. Munro, 1998, Annals of the rheumatic diseases.

Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients?

R. Madhok, H. Capell, E. Thomson, 1999, Annals of the rheumatic diseases.

REPORTS Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients ?

R. Madhok, H. Capell, E. Thomson, 1999 .

Can intervention modify adverse lifestyle variables in a rheumatoid population? Results of a pilot study

R. Madhok, H. Capell, M. Gordon, 2002, Annals of the rheumatic diseases.

Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine.

H. Capell, E. Thomson, R. Hampson, 1998, The Journal of rheumatology.

ect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis

R. Madhok, D. Porter, H. Capell, 1998 .

E V ect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis

R. Madhok, D. Porter, H. Capell, 1998 .